<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">339324</id>
  <title nil="true"/>
  <common-name>3-hydroxy-n,n-bis(2-hydroxyethyl)-4-[(3-methyl-5-oxo-1-phenyl-4h-pyrazol-4-yl)diazenyl]naphthalene-1-sulfonamide</common-name>
  <description>3-hydroxy-n,n-bis(2-hydroxyethyl)-4-[(3-methyl-5-oxo-1-phenyl-4h-pyrazol-4-yl)diazenyl]naphthalene-1-sulfonamide is a chemical compound with the formula C24H25N5O6S. With an average molecular weight of 511.60 g/mol, 3-hydroxy-n,n-bis(2-hydroxyethyl)-4-[(3-methyl-5-oxo-1-phenyl-4h-pyrazol-4-yl)diazenyl]naphthalene-1-sulfonamide is a heavy molecule.</description>
  <cas>66142-94-7</cas>
  <pubchem-id>105294</pubchem-id>
  <chemical-formula>C24H25N5O6S</chemical-formula>
  <weight>511.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T22:36:52Z</created-at>
  <updated-at type="dateTime">2026-08-30T22:36:52Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=NN(C(=O)C1N=NC2=C(C=C(C3=CC=CC=C32)S(=O)(=O)N(CCO)CCO)O)C4=CC=CC=C4</moldb-smiles>
  <moldb-formula>C24H25N5O6S</moldb-formula>
  <moldb-inchi>InChI=1S/C24H25N5O6S/c1-16-22(24(33)29(27-16)17-7-3-2-4-8-17)25-26-23-19-10-6-5-9-18(19)21(15-20(23)32)36(34,35)28(11-13-30)12-14-31/h2-10,15,22,30-32H,11-14H2,1H3</moldb-inchi>
  <moldb-inchikey>NPCQCUDIAGLXGU-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">511.1525547</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM335217</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-hydroxy-n,n-bis(2-hydroxyethyl)-4-[(3-methyl-5-oxo-1-phenyl-4h-pyrazol-4-yl)diazenyl]naphthalene-1-sulfonamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Naphthalenes</klass>
  <subklass>Naphthalene sulfonic acids and derivatives</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0289745</sync-id>
  <structure-inchikey>NPCQCUDIAGLXGU-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000008000000000000800000000000000000000000000140800002001000000000000000000020000008060000002004900000000000000800004000000000000000008800000000000000000000000020000000000000000004000000000000000000010100000000000000104000000000001100000000000000000000100000004040000000800000000000000000000000000100000200000000000000000100000000802000040008080000400800000000000000080000110000010000000000040000002100000000000000400000000000002000000200000000000000000040000000000040000000000000000041400000000000001000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMGACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:39:51Z</structure-indexed-at>
</compound>
